Abstract |
Fourteen cases of adenocarcinoma with pleuritis carcinomatosa ( lung cancer 10 cases, ovarian cancer 2 cases, colon cancer 2 cases) were treated with intra-pleural instillation of 7-N-(p-hydroxyphenyl)-mitomycin C (KW-2083), a derivative of mitomycin C. KW-2083 was administered at a dose of 40 mg once or twice weekly. In 14 evaluable patients, the rate of decrease of pleural fluid was 79%, and that of disappearance of tumor cells in pleural fluid was 64%. Median survival time (MST) from the beginning of treatment in all cases was 163 days. The toxicities of intrapleural instillation of KW-2083 were chest pain (86%), transient fever (64%), anorexia (64%), fatigability (29%), nausea (21%), vomiting (21%) and thrombocytopenia (nadir: 3.5 X 10(4)/mm3; 7%). Serum and pleural fluid KW-2083 concentrations have been measured in 3 patients after intrapleural administration of KW-2083. The mean half life of KW-2083 in serum and pleural fluid was 74 min (69-78 min) and 56 min (33-70 min), respectively. The peak serum KW-2083 concentration was 0.18 microgram/ml (0.06-0.24 microgram/ml).
|
Authors | E Shimizu, N Saijo, T Shinkai, K Eguchi, K Tominaga, H Nomori, Y Sasaki, P Garcia-Herreros, A Hoshi |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 11
Issue 6
Pg. 1290-5
(Jun 1984)
ISSN: 0385-0684 [Print] Japan |
PMID | 6732255
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Mitomycins
- Mitomycin
- 7-N-(4-hydroxyphenyl)mitomycin C
|
Topics |
- Adenocarcinoma
(complications)
- Adult
- Aged
- Anorexia
(chemically induced)
- Antineoplastic Agents
(administration & dosage, adverse effects)
- Colonic Neoplasms
(complications)
- Female
- Fever
(chemically induced)
- Humans
- Lung Neoplasms
(complications)
- Male
- Middle Aged
- Mitomycin
- Mitomycins
(administration & dosage, adverse effects)
- Nausea
(chemically induced)
- Ovarian Neoplasms
(complications)
- Pain
(chemically induced)
- Pleurisy
(drug therapy, etiology)
- Thorax
|